RetroSearch Browse

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/33464343/ below:

Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement

Practice Guideline

. 2021 Jan 19;325(3):265-279. doi: 10.1001/jama.2020.25019. Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement Alex H Krist^{1 2}, Karina W Davidson³, Carol M Mangione⁴, Michael J Barry⁵, Michael Cabana⁶, Aaron B Caughey⁷, Katrina Donahue⁸, Chyke A Doubeni⁹, John W Epling Jr¹⁰, Martha Kubik¹¹, Gbenga Ogedegbe¹², Lori Pbert¹³, Michael Silverstein¹⁴, Melissa A Simon¹⁵, Chien-Wen Tseng^{16 17}, John B Wong¹⁸

Affiliations

¹ Fairfax Family Practice Residency, Fairfax, Virginia.
² Virginia Commonwealth University, Richmond.
³ Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York.
⁴ University of California, Los Angeles.
⁵ Harvard Medical School, Boston, Massachusetts.
⁶ University of California, San Francisco.
⁷ Oregon Health & Science University, Portland.
⁸ University of North Carolina at Chapel Hill.
⁹ Mayo Clinic, Rochester, Minnesota.
¹⁰ Virginia Tech Carilion School of Medicine, Roanoke.
¹¹ George Mason University, Fairfax, Virginia.
¹² New York University, New York, New York.
¹³ University of Massachusetts Medical School, Worcester.
¹⁴ Boston University, Boston, Massachusetts.
¹⁵ Northwestern University, Evanston, Illinois.
¹⁶ University of Hawaii, Honolulu.
¹⁷ Pacific Health Research and Education Institute, Honolulu, Hawaii.
¹⁸ Tufts University School of Medicine, Boston, Massachusetts.

PMID: 33464343
DOI: 10.1001/jama.2020.25019

Item in Clipboard

Practice Guideline

Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force et al. JAMA. 2021.

. 2021 Jan 19;325(3):265-279. doi: 10.1001/jama.2020.25019. Authors US Preventive Services Task Force; Alex H Krist^{1 2}, Karina W Davidson³, Carol M Mangione⁴, Michael J Barry⁵, Michael Cabana⁶, Aaron B Caughey⁷, Katrina Donahue⁸, Chyke A Doubeni⁹, John W Epling Jr¹⁰, Martha Kubik¹¹, Gbenga Ogedegbe¹², Lori Pbert¹³, Michael Silverstein¹⁴, Melissa A Simon¹⁵, Chien-Wen Tseng^{16 17}, John B Wong¹⁸ Affiliations

¹ Fairfax Family Practice Residency, Fairfax, Virginia.
² Virginia Commonwealth University, Richmond.
³ Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York.
⁴ University of California, Los Angeles.
⁵ Harvard Medical School, Boston, Massachusetts.
⁶ University of California, San Francisco.
⁷ Oregon Health & Science University, Portland.
⁸ University of North Carolina at Chapel Hill.
⁹ Mayo Clinic, Rochester, Minnesota.
¹⁰ Virginia Tech Carilion School of Medicine, Roanoke.
¹¹ George Mason University, Fairfax, Virginia.
¹² New York University, New York, New York.
¹³ University of Massachusetts Medical School, Worcester.
¹⁴ Boston University, Boston, Massachusetts.
¹⁵ Northwestern University, Evanston, Illinois.
¹⁶ University of Hawaii, Honolulu.
¹⁷ Pacific Health Research and Education Institute, Honolulu, Hawaii.
¹⁸ Tufts University School of Medicine, Boston, Massachusetts.

PMID: 33464343
DOI: 10.1001/jama.2020.25019

Item in Clipboard

Abstract

Importance: Tobacco use is the leading preventable cause of disease, disability, and death in the US. In 2014, it was estimated that 480 000 deaths annually are attributed to cigarette smoking, including second hand smoke exposure. Smoking during pregnancy can increase the risk of numerous adverse pregnancy outcomes (eg, miscarriage and congenital anomalies) and complications in the offspring (including sudden infant death syndrome and impaired lung function in childhood). In 2019, an estimated 50.6 million US adults (20.8% of the adult population) used tobacco; 14.0% of the US adult population currently smoked cigarettes and 4.5% of the adult population used electronic cigarettes (e-cigarettes). Among pregnant US women who gave birth in 2016, 7.2% reported smoking cigarettes while pregnant.

Objective: To update its 2015 recommendation, the USPSTF commissioned a review to evaluate the benefits and harms of primary care interventions on tobacco use cessation in adults, including pregnant persons.

Population: This recommendation statement applies to adults 18 years or older, including pregnant persons.

Evidence assessment: The USPSTF concludes with high certainty that the net benefit of behavioral interventions and US Food and Drug Associated (FDA)-approved pharmacotherapy for tobacco smoking cessation, alone or combined, in nonpregnant adults who smoke is substantial. The USPSTF concludes with high certainty that the net benefit of behavioral interventions for tobacco smoking cessation on perinatal outcomes and smoking cessation in pregnant persons is substantial. The USPSTF concludes that the evidence on pharmacotherapy interventions for tobacco smoking cessation in pregnant persons is insufficient because few studies are available, and the balance of benefits and harms cannot be determined. The USPSTF concludes that the evidence on the use of e-cigarettes for tobacco smoking cessation in adults, including pregnant persons, is insufficient, and the balance of benefits and harms cannot be determined. The USPSTF has identified the lack of well-designed, randomized clinical trials on e-cigarettes that report smoking abstinence or adverse events as a critical gap in the evidence.

Recommendations: The USPSTF recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and FDA-approved pharmacotherapy for cessation to nonpregnant adults who use tobacco. (A recommendation) The USPSTF recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco. (A recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of e-cigarettes for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety. (I statement).

PubMed Disclaimer